Determination of the most informative prognostic parameters for assessing the status of the epidermal growth factor receptor Her2/neu in the primary tumor in breast cancer patients using the targeted radiopharmaceutical «99mTc-ADAPT6». Voprosy onkologii, v. 67, n. 3, p. 368–373, 6 Jul.2021.